2019 BAP循证指南:精神分裂症的药物治疗(更新版)

2019-12-12 英国精神药理协会 J Psychopharmacol. 2019 Dec 12.

2019年12月,英国精神药理协会(BAP)发布了精神分裂症的药物治疗指南,该指南是对2011年版指南的更新,专家组讨论了精神分裂症药物治疗的目标和范围。指南涵盖了精神分裂症各个阶段的药物治疗,包括首发、复发和对标准治疗方法无效的疾病。

中文标题:

2019 BAP循证指南:精神分裂症的药物治疗(更新版)

英文标题:

Evidence-based guidelines for the pharmacological treatment of schizophrenia: Updated recommendations from the British Association for Psychopharmacology.

发布机构:

英国精神药理协会

发布日期:

2019-12-12

简要介绍:

2019年12月,英国精神药理协会(BAP)发布了精神分裂症的药物治疗指南,该指南是对2011年版指南的更新,专家组讨论了精神分裂症药物治疗的目标和范围。指南涵盖了精神分裂症各个阶段的药物治疗,包括首发、复发和对标准治疗方法无效的疾病。

 

拓展指南:精神分裂症相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=2019 BAP循证指南:精神分裂症的药物治疗(更新版))] GetToolGuiderByIdResponse(projectId=1, id=5633b1c0018a65b7, title=2019 BAP循证指南:精神分裂症的药物治疗(更新版), enTitle=Evidence-based guidelines for the pharmacological treatment of schizophrenia: Updated recommendations from the British Association for Psychopharmacology., guiderFrom=J Psychopharmacol. 2019 Dec 12., authorId=null, author=, summary=2019年12月,英国精神药理协会(BAP)发布了精神分裂症的药物治疗指南,该指南是对2011年版指南的更新,专家组讨论了精神分裂症药物治疗的目标和范围。指南涵盖了精神分裂症各个阶段的药物治疗,包括首发、复发和对标准治疗方法无效的疾病。 , cover=, journalId=null, articlesId=null, associationId=909, associationName=英国精神药理协会, associationIntro=null, copyright=0, guiderPublishedTime=Thu Dec 12 00:00:00 CST 2019, originalUrl=, linkOutUrl=, content=<P>2019年12月,英国精神药理协会(BAP)发布了精神分裂症的药物治疗指南,该指南是对2011年版指南的更新,专家组讨论了精神分裂症药物治疗的目标和范围。指南涵盖了精神分裂症各个阶段的药物治疗,包括首发、复发和对标准治疗方法无效的疾病。 </P> <P> </P>拓展指南:<strong>与<font color=red>精神分裂症</font>相关指南:</strong><br><ul><li><a href="https://www.medsci.cn/guideline/show_article.do?id=564dd1c001a33879" title="WFSBP 精神分裂症的生物学治疗指南(初级医疗精简版)" target=_blank>WFSBP 精神分裂症的生物学治疗指南(初级医疗精简版)</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=f0d281c0013a1554" title="2016 TRRIP工作组共识指南:难治性精神分裂症的诊断和定义" target=_blank>2016 TRRIP工作组共识指南:难治性精神分裂症的诊断和定义</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=674c81c00131e0c5" title="2016 应用长效可注射性抗精神病药物治疗精神分裂症:证据评估" target=_blank>2016 应用长效可注射性抗精神病药物治疗精神分裂症:证据评估</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=116681c001209666" title="2016NICE:儿童和青少年精神病和精神分裂症:识别和管理指南更新" target=_blank>2016NICE:儿童和青少年精神病和精神分裂症:识别和管理指南更新</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=a33cd1c0011e7977" title="2016 RANZCP临床实践指南:精神分裂症及其相关疾病的管理" target=_blank>2016 RANZCP临床实践指南:精神分裂症及其相关疾病的管理</a></li> 更多信息请点击:<a href="https://www.medsci.cn/guideline/list.do?q=%E7%B2%BE%E7%A5%9E%E5%88%86%E8%A3%82%E7%97%87" target=_blank>有关精神分裂症更多指南</a></ul>, tagList=[TagDto(tagId=1344, tagName=精神分裂症), TagDto(tagId=1113, tagName=药物治疗)], categoryList=[CategoryDto(categoryId=13, categoryName=精神心理科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=0, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=15384, appHits=440, showAppHits=44, pcHits=3986, showPcHits=13484, likes=40, shares=75, comments=7, approvalStatus=1, publishedTime=Mon Dec 30 23:35:24 CST 2019, publishedTimeString=2019-12-12, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Mon Dec 30 23:35:24 CST 2019, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 01:53:50 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2019 BAP循证指南:精神分裂症的药物治疗(更新版))])
2019 BAP循证指南:精神分裂症的药物治疗(更新版)
下载请点击:
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1249116, encodeId=7b201249116a8, content=学习了 希望多发些指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b218327465, createdName=ms5000000827060406, createdTime=Thu Sep 15 16:38:39 CST 2022, time=2022-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001079, encodeId=9f9410010e91f, content=啦咯啦咯啦咯来咯, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81955477682, createdName=ms4000000599238185, createdTime=Tue Jul 20 10:40:11 CST 2021, time=2021-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971168, encodeId=1f899e116844, content=是需要药物维持治疗的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=456a5390609, createdName=ms5000001355507656, createdTime=Sat Jun 05 19:49:40 CST 2021, time=2021-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962785, encodeId=1307962e85bf, content=怎么得积分啊 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210508/226bbe1c4f974b688f80ff014172cabc/101e3d3a8ee14d599d3925031f5c9a4b.jpg, createdBy=27b05492475, createdName=精神科医生, createdTime=Wed May 05 11:54:39 CST 2021, time=2021-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958874, encodeId=7a849588e498, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210420/7c5c53fbde0e4181bbfe9fa9330b16e1/aaa7301f2e7f488faff67f9f31895373.jpg, createdBy=4d9f5480726, createdName=huhuanyi, createdTime=Tue Apr 20 21:21:09 CST 2021, time=2021-04-20, status=1, ipAttribution=)]
    2022-09-15 ms5000000827060406

    学习了 希望多发些指南

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1249116, encodeId=7b201249116a8, content=学习了 希望多发些指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b218327465, createdName=ms5000000827060406, createdTime=Thu Sep 15 16:38:39 CST 2022, time=2022-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001079, encodeId=9f9410010e91f, content=啦咯啦咯啦咯来咯, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81955477682, createdName=ms4000000599238185, createdTime=Tue Jul 20 10:40:11 CST 2021, time=2021-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971168, encodeId=1f899e116844, content=是需要药物维持治疗的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=456a5390609, createdName=ms5000001355507656, createdTime=Sat Jun 05 19:49:40 CST 2021, time=2021-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962785, encodeId=1307962e85bf, content=怎么得积分啊 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210508/226bbe1c4f974b688f80ff014172cabc/101e3d3a8ee14d599d3925031f5c9a4b.jpg, createdBy=27b05492475, createdName=精神科医生, createdTime=Wed May 05 11:54:39 CST 2021, time=2021-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958874, encodeId=7a849588e498, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210420/7c5c53fbde0e4181bbfe9fa9330b16e1/aaa7301f2e7f488faff67f9f31895373.jpg, createdBy=4d9f5480726, createdName=huhuanyi, createdTime=Tue Apr 20 21:21:09 CST 2021, time=2021-04-20, status=1, ipAttribution=)]
    2021-07-20 ms4000000599238185

    啦咯啦咯啦咯来咯

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1249116, encodeId=7b201249116a8, content=学习了 希望多发些指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b218327465, createdName=ms5000000827060406, createdTime=Thu Sep 15 16:38:39 CST 2022, time=2022-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001079, encodeId=9f9410010e91f, content=啦咯啦咯啦咯来咯, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81955477682, createdName=ms4000000599238185, createdTime=Tue Jul 20 10:40:11 CST 2021, time=2021-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971168, encodeId=1f899e116844, content=是需要药物维持治疗的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=456a5390609, createdName=ms5000001355507656, createdTime=Sat Jun 05 19:49:40 CST 2021, time=2021-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962785, encodeId=1307962e85bf, content=怎么得积分啊 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210508/226bbe1c4f974b688f80ff014172cabc/101e3d3a8ee14d599d3925031f5c9a4b.jpg, createdBy=27b05492475, createdName=精神科医生, createdTime=Wed May 05 11:54:39 CST 2021, time=2021-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958874, encodeId=7a849588e498, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210420/7c5c53fbde0e4181bbfe9fa9330b16e1/aaa7301f2e7f488faff67f9f31895373.jpg, createdBy=4d9f5480726, createdName=huhuanyi, createdTime=Tue Apr 20 21:21:09 CST 2021, time=2021-04-20, status=1, ipAttribution=)]
    2021-06-05 ms5000001355507656

    是需要药物维持治疗的

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1249116, encodeId=7b201249116a8, content=学习了 希望多发些指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b218327465, createdName=ms5000000827060406, createdTime=Thu Sep 15 16:38:39 CST 2022, time=2022-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001079, encodeId=9f9410010e91f, content=啦咯啦咯啦咯来咯, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81955477682, createdName=ms4000000599238185, createdTime=Tue Jul 20 10:40:11 CST 2021, time=2021-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971168, encodeId=1f899e116844, content=是需要药物维持治疗的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=456a5390609, createdName=ms5000001355507656, createdTime=Sat Jun 05 19:49:40 CST 2021, time=2021-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962785, encodeId=1307962e85bf, content=怎么得积分啊 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210508/226bbe1c4f974b688f80ff014172cabc/101e3d3a8ee14d599d3925031f5c9a4b.jpg, createdBy=27b05492475, createdName=精神科医生, createdTime=Wed May 05 11:54:39 CST 2021, time=2021-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958874, encodeId=7a849588e498, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210420/7c5c53fbde0e4181bbfe9fa9330b16e1/aaa7301f2e7f488faff67f9f31895373.jpg, createdBy=4d9f5480726, createdName=huhuanyi, createdTime=Tue Apr 20 21:21:09 CST 2021, time=2021-04-20, status=1, ipAttribution=)]
    2021-05-05 精神科医生

    怎么得积分啊

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1249116, encodeId=7b201249116a8, content=学习了 希望多发些指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b218327465, createdName=ms5000000827060406, createdTime=Thu Sep 15 16:38:39 CST 2022, time=2022-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001079, encodeId=9f9410010e91f, content=啦咯啦咯啦咯来咯, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81955477682, createdName=ms4000000599238185, createdTime=Tue Jul 20 10:40:11 CST 2021, time=2021-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971168, encodeId=1f899e116844, content=是需要药物维持治疗的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=456a5390609, createdName=ms5000001355507656, createdTime=Sat Jun 05 19:49:40 CST 2021, time=2021-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962785, encodeId=1307962e85bf, content=怎么得积分啊 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210508/226bbe1c4f974b688f80ff014172cabc/101e3d3a8ee14d599d3925031f5c9a4b.jpg, createdBy=27b05492475, createdName=精神科医生, createdTime=Wed May 05 11:54:39 CST 2021, time=2021-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958874, encodeId=7a849588e498, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210420/7c5c53fbde0e4181bbfe9fa9330b16e1/aaa7301f2e7f488faff67f9f31895373.jpg, createdBy=4d9f5480726, createdName=huhuanyi, createdTime=Tue Apr 20 21:21:09 CST 2021, time=2021-04-20, status=1, ipAttribution=)]
    2021-04-20 huhuanyi

    学习一下

    0